| View |
|
DR-XY45480
|
Sultamicillin (as Tosilate Dihydrate)
|
Unacil
|
750mg
|
Tablet
|
Antibacterial
|
Swiss Parenterals Pvt. Ltd.
|
India
|
Automatic Renewal
|
22 July 2021
|
01 July 2026
|
| View |
|
DR-XY45484
|
Lidocaine (As Hydrochloride)
|
Senzitene
|
2mg/mL (2%)
|
Solution for Injection (I.M./I.V.)
|
-
|
Jiangsu Ruinian Qianjin Pharmaceutical Co., Ltd.
|
China
|
-
|
26 February 2021
|
01 July 2026
|
| View |
|
DR-XY45489
|
Dexamethasone Sodium Phosphate
|
Dexasone
|
1mg/mL (0.1%w/v)
|
Ophthalmic Solution (Eye Drops)
|
-
|
The IBN SINA Pharmaceutical Industry Ltd.
|
Bangladesh
|
Automatic Renewal
|
14 May 2021
|
05 July 2026
|
| View |
|
DR-XY45490
|
Amlodipine (as besilate) + Valsartan
|
Avsar
|
5 mg/80 mg
|
Film Coated Tablet
|
-
|
Pharmevo (Pvt.) Ltd.
|
Pakistan
|
Automatic Renewal
|
03 May 2021
|
05 July 2026
|
| View |
|
DR-XY45491
|
Amlodipine (as besilate) + Valsartan
|
Avsar
|
10 mg /160 mg
|
Film Coated Tablet
|
-
|
Pharmevo (Pvt.) Ltd.
|
Pakistan
|
Automatic Renewal
|
03 May 2021
|
05 July 2026
|
| View |
|
DR-XY45493
|
Pantoprazole (as sodium)
|
Hypanto-20
|
20mg
|
Delayed-Release Tablet
|
PROTON PUMP INHIBITOR
|
Hiral Labs Ltd.
|
India
|
Automatic Renewal
|
16 September 2021
|
05 July 2026
|
| View |
|
DR-XY45496
|
Omeprazole
|
None
|
40mg
|
Delayed-Release Capsule
|
Proton Pump Inhibitor
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
08 February 2022
|
05 July 2026
|
| View |
|
DR-XY45497
|
Bepotastine besilate
|
Bepotas
|
15 mg/mL (1.5% w/v)
|
Ophthalmic Solution (Eye Drops)
|
Histamine H1 Receptor Antagonist
|
Aristopharma Ltd.
|
Bangladesh
|
Initial (from Monitored Release)
|
17 October 2022
|
14 July 2026
|
| View |
|
DR-XY45498
|
Fluconazole
|
Fleozol
|
200 mg
|
Film-Coated Tablet
|
Antimycotic (Triazole Derivative)
|
Helviina Pharmaceuticals Pvt. Ltd.
|
India
|
Automatic Renewal
|
07 June 2021
|
08 July 2026
|
| View |
|
DR-XY45499
|
Valsartan + Hydrochlorothiazide
|
Valstan HCT 80/25
|
80 mg/25 mg
|
Film-Coated Tablet
|
Antihypertensive
|
Rhydburg Pharmaceutical Ltd.
|
India
|
Automatic Renewal
|
20 July 2021
|
08 July 2026
|
| View |
|
DR-XY45501
|
Doxycycline (As Hyclate)
|
Doxycline
|
100mg
|
Capsule
|
-
|
Bal Pharma Limited
|
India
|
-
|
20 May 2021
|
11 July 2026
|
| View |
|
DR-XY45503
|
Mometasone furoate Monohydrate
|
MOMATE
|
50mcg / actuation
|
Nasal Spray Suspension
|
Corticosteroid
|
Glenmark Pharmaceuticals Ltd.
|
India
|
Renewal
|
03 August 2021
|
14 July 2026
|
| View |
|
DR-XY45504
|
Zipromin
|
Ciprofloxacin (As Lactate)
|
200 mg/100mL (2 mg/mL)
|
Solution For I.V. Infusion
|
-
|
Jinling Pharmaceutical Co., Ltd.
|
China
|
-
|
12 May 2021
|
13 July 2026
|
| View |
|
DR-XY45505
|
Utexyn
|
Oxytocin
|
5 IU/mL
|
Solution for Injection (IM/SC/IV)
|
-
|
Gland Pharma Limited
|
India
|
-
|
14 May 2021
|
22 July 2026
|
| View |
|
DR-XY45507
|
Irbesartan + Amlodipine (as besilate)
|
Aprovasc
|
300 mg/5 mg
|
Film-Coated Tablet
|
Angiotensin II receptor blocker and calcium channel
blocker
|
Sanofi-Aventis De Mexico, S.A. De C.V.
|
Mexico
|
Initial (from Monitored release)
|
06 June 2022
|
14 July 2026
|
| View |
|
DR-XY45508
|
Irbesartan + Amlodipine (As Besilate)
|
Aprovasc
|
300/10 mg
|
Film-Coated Tablet
|
-
|
Sanofi-Aventis De Mexico, S.A. De C.V.
|
Mexico
|
Initial [from Monitored Release]
|
09 December 2022
|
14 July 2026
|
| View |
|
DR-XY45509
|
Irbesartan + Amlodipine (as besilate)
|
Aprovasc
|
150/5 mg
|
Film-Coated Tablet
|
Antihypertensive (Angiotensin II Receptor Blocker/
Calcium Channel Blocker combination)
|
Sanofi Aventis De México S.A. De C.V.
|
Mexico
|
Initial (from Monitored Release)
|
08 February 2023
|
14 July 2026
|
| View |
DR-XY45510_PI_01.pdf
|
DR-XY45510
|
Sofosbuvir
|
Myhep
|
400 mg
|
Tablet
|
-
|
Mylan Laboratories Limited
|
India
|
Initial (from Monitored Release)
|
05 December 2022
|
26 August 2026
|
| View |
|
DR-XY45513
|
Each gram contains: Polymyxin B sulfate- eq. to 10000 units; Neomycin sulfate- eq. to 3400 units; Bacitracin Zinc- eq. to 500 units
|
Tribac
|
Refer to generic name
|
Ophthalmic Ointment
|
-
|
Remington Pharmaceutical Industries (Pvt.) Ltd.
|
Pakistan
|
Automatic Renewal
|
18 June 2021
|
20 July 2026
|
| View |
|
DR-XY45521
|
Natamycin
|
N-Mycin
|
50 mg/mL (5% w/v)
|
Ophthalmic Suspension (Eye Drops)
|
Anti-Infective
|
Aristopharma Ltd.
|
Bangladesh
|
Initial (from Monitored Release)
|
17 October 2022
|
22 July 2026
|